Related Experiment Video
Updated: Jan 25, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
3D bioprinting of vascular conduits for pediatric congenital heart repairs
Wenhan Lee1, Yi Hong2, Guohao Dai1
1Department of Bioengineering, Northeastern University, Boston, Massachusetts.
Insights
Tissue engineered vascular grafts (TEVGs) are crucial for pediatric congenital heart defect repair. Current research focuses on 3D bioprinting for patient-specific grafts, aiming for improved long-term performance.
Area of Science:
- Biomedical Engineering
- Pediatric Cardiology
- Regenerative Medicine
Background:
- Congenital heart defects in children necessitate surgical correction using grafts, patches, or conduits.
- Pediatric cardiovascular anatomy varies, requiring tailored surgical approaches and precisely designed grafts sensitive to hemodynamic environments.
- Tissue engineered vascular grafts (TEVGs) show promise but fabricating patient- and operation-specific grafts remains challenging.
Purpose of the Study:
- To review historical milestones and clinical outcomes of TEVG development for pediatric congenital defect repair.
- To highlight advancements in 3D bioprinting of TEVGs with complex geometries.
- To address current limitations in TEVG fabrication and future research directions.
Main Methods:
- Review of historical development and clinical outcomes of TEVGs in pediatric surgery.
- Analysis of current research on 3D bioprinting techniques for TEVG fabrication.
- Discussion of challenges and limitations associated with TEVG technologies.
Main Results:
- Significant progress has been made in TEVG development over the past decade.
- 3D bioprinting offers potential for creating TEVGs with complex, patient-specific geometries.
- Current 3D bioprinted vascular grafts lack appropriate functions, but research is promising.
Conclusions:
- Developing functional, patient-specific TEVGs for pediatric congenital heart defect repair is an ongoing challenge.
- 3D bioprinting represents a promising avenue for future TEVG innovation.
- Continued research is essential to overcome limitations and achieve successful clinical application of TEVGs.
Abstract:
In children with congenital heart defects, surgical correction often involves the use of valves, patches or vascular conduits to establish anatomic continuity. Due to the differences between the pediatric and adult populations, tissue reconstruction in pediatric patients requires a substantially different approach from those in adults. Cardiovascular anatomy of children with congenital heart defect vary, which requires tailored surgical operations for each patient. Since grafts used in these palliative surgeries are sensitive to the local hemodynamic environments, their geometries need to be precisely designed to ensure long-term performance. Tissue engineered vascular grafts (TEVGs) have made tremendous progress over the past decade, but it remains difficult to fabricate patient- and operation-specific vascular grafts. This review summarizes historical milestones of TEVG development for repairing pediatric congenital defects and current clinical outcomes. We also highlight ongoing works on 3D bioprinting of TEVGs with complex geometries and address the current limitations of each technique. Although 3D bioprinted vascular grafts with appropriate functions are yet to be developed, some of the current researches are promising to create better patient specific tissue engineered vascular grafts in the future.
Related Concept Videos
Mismatch Repair
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Overview of DNA Repair
Chemically...
Base Excision Repair
The first step of...
Nucleotide Excision Repair
Long-patch Base Excision Repair

